A Study to Determine the Dose of WIN-1001X by Evaluating Efficacy and Safety in Early Parkinson's Disease Patients Trial Phase 2 Unknown Feb. 23, 2021
An Exploratory Study Investigating Safety, Tolerability and Pharmacokinetics of Ascending Doses of Lu AE04621 in Parkinson Disease Patients Trial Phase 1 Completed Feb. 23, 2021
Antigen Presentation and Lymphocyte Response in Parkinson's Disease Trial N/A Completed Feb. 20, 2021
A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects Trial Phase 2 Completed Feb. 17, 2021
The Effect of Kinesiophobia on Physical Activity, Balance and Falling in Parkinson's Disease Patients Trial N/A Completed Feb. 17, 2021
A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease. Trial Phase 2 Completed Feb. 16, 2021
Multifocal Neuromodulation in Motor and Cognitive Function of People With Parkinson's Disease Trial N/A Unknown Feb. 16, 2021
Study of Factors Associated With the Volumetric and Areal Bone Mineral Density and Bone Strength in Parkinson's Disease Trial N/A Unknown Feb. 15, 2021
The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa Trial Phase 4 Completed Feb. 15, 2021
Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease Experiments 1 & 2 - Proj #3 Trial Phase 2 Completed Feb. 11, 2021
Evaluation of a Multimodal Neuroimaging Method for Diagnosis in Parkinsonian Syndromes Trial N/A Completed Feb. 8, 2021
Exploration of the Mechanism of Movement Improvement During RBD in Parkinson's Disease Using NIRS Trial N/A Completed Feb. 8, 2021
LRRK2 Activity and Markers of Parkinson's Disease in G2385R Carriers Trial N/A Completed Feb. 8, 2021